CASTAGNA, Annalisa
 Distribuzione geografica
Continente #
NA - Nord America 7.555
EU - Europa 6.385
AS - Asia 4.540
SA - Sud America 639
Continente sconosciuto - Info sul continente non disponibili 168
AF - Africa 145
OC - Oceania 14
Totale 19.446
Nazione #
US - Stati Uniti d'America 7.402
RU - Federazione Russa 2.665
SG - Singapore 1.788
CN - Cina 1.291
GB - Regno Unito 1.097
IT - Italia 556
DE - Germania 513
BR - Brasile 492
VN - Vietnam 441
SE - Svezia 357
HK - Hong Kong 341
FR - Francia 305
IE - Irlanda 262
FI - Finlandia 257
KR - Corea 136
BD - Bangladesh 111
JP - Giappone 101
CA - Canada 89
IN - India 84
UA - Ucraina 74
AR - Argentina 72
NL - Olanda 54
BE - Belgio 45
TR - Turchia 39
ID - Indonesia 38
ZA - Sudafrica 37
PL - Polonia 34
ES - Italia 33
IQ - Iraq 33
MX - Messico 33
NG - Nigeria 33
LT - Lituania 19
AT - Austria 17
CL - Cile 17
VE - Venezuela 17
PK - Pakistan 16
RO - Romania 14
CO - Colombia 13
AU - Australia 12
CH - Svizzera 12
EG - Egitto 11
IL - Israele 11
KE - Kenya 11
SA - Arabia Saudita 11
UZ - Uzbekistan 11
MA - Marocco 10
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
EC - Ecuador 8
HR - Croazia 8
IR - Iran 8
JM - Giamaica 8
MY - Malesia 8
NP - Nepal 8
DZ - Algeria 7
GR - Grecia 7
PH - Filippine 7
PT - Portogallo 7
TG - Togo 7
TN - Tunisia 7
BJ - Benin 6
UY - Uruguay 6
BG - Bulgaria 5
BO - Bolivia 5
LB - Libano 5
LV - Lettonia 5
PE - Perù 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BH - Bahrain 4
CR - Costa Rica 4
DK - Danimarca 4
EE - Estonia 4
ET - Etiopia 4
HN - Honduras 4
JO - Giordania 4
KG - Kirghizistan 4
KZ - Kazakistan 4
RS - Serbia 4
HU - Ungheria 3
NO - Norvegia 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
GP - Guadalupe 2
GT - Guatemala 2
LK - Sri Lanka 2
MD - Moldavia 2
OM - Oman 2
PY - Paraguay 2
SI - Slovenia 2
SR - Suriname 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BN - Brunei Darussalam 1
Totale 19.253
Città #
Singapore 1.011
Moscow 922
Ashburn 871
Southend 856
Dallas 801
Chandler 741
San Jose 643
Jacksonville 510
Ann Arbor 359
Hong Kong 333
Woodbridge 307
Verona 267
Dublin 263
Beijing 221
Houston 220
New York 208
The Dalles 196
Council Bluffs 159
Ho Chi Minh City 142
Los Angeles 128
Wilmington 119
Munich 117
Lawrence 102
Princeton 102
Tokyo 95
Jinan 85
Hanoi 82
Nanjing 77
Boardman 76
Helsinki 72
Santa Clara 72
Shenyang 70
Buffalo 56
São Paulo 54
Redondo Beach 49
Brussels 45
Columbus 42
Hebei 42
Milan 41
Tianjin 38
Turku 38
Orem 37
Montreal 36
Redmond 35
London 34
Sindelfingen 34
Lancaster 33
Zhengzhou 32
Abuja 31
Changsha 31
Haikou 29
Nanchang 29
Johannesburg 28
Brooklyn 27
Seattle 27
Jiaxing 25
Rio de Janeiro 25
Warsaw 25
Guangzhou 24
Denver 23
Hangzhou 23
Chicago 22
Toronto 22
Chennai 21
Falkenstein 21
Frankfurt am Main 21
Jakarta 21
Phoenix 21
Seoul 21
Amsterdam 20
Dong Ket 20
Haiphong 20
Taiyuan 20
Padova 19
Atlanta 18
Ningbo 18
Taizhou 17
Da Nang 16
Poplar 16
Stockholm 16
Falls Church 15
Norwalk 15
Shanghai 15
Vienna 15
Hải Dương 14
Manchester 14
Nürnberg 14
San Francisco 14
Fuzhou 13
Mumbai 13
Rome 13
Washington 13
Ankara 12
Barnet 12
Buenos Aires 12
Fairfield 12
Mexico City 12
Zurich 12
Baghdad 11
Boston 11
Totale 11.852
Nome #
Epigenetic Regulation Through Histone Deacetylation: Implications and Therapeutic Potential in Hepatocellular Carcinoma 343
Increased urinary excretion of the epithelial Na channel activator prostasin in patients with primary aldosteronism 319
Apolipoprotein -CIII glycoforms correlate heterogeneously with plasma lipid profile in subjects with coronary artery disease 253
ApoCIII glycoforms determination and proteomic analysis in plasma of coronary patients with different ApoCIII levels . 229
Urinary protease inhibitor Serpin B3 is higher in women and is further increased in female patients affected by aldosterone producing adenoma 228
Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin 219
Urinary prostasin in normotensive individuals: correlation with the aldosterone to renin ratio and urinary sodium. 218
HEPCIDIN REPRESSION BY PROMOTER DNA HYPERMETHYLATION IN NON-VIRAL HEPATOCELLULAR CARCINOMA 212
Hepcidin and DNA promoter methylation in hepatocellular carcinoma 211
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 210
A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients? 208
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 207
Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study. 206
Identification of new BMP6 pro-peptide mutations in patients with iron overload 201
Isoelectric beads for proteome pre-fractionation.II :experimental evaluation in a multicompartment electroyzer 199
miRNAs purification and analysis from urinary exosomes. 199
Altered iron parameters and hepcidin levels in a general population: lesson from the CHRIS study 199
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 196
The proteome: anno Domini 2002 195
Immunoaffinity reactors for prion protein qualitative analysis 195
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 194
Comparative two-dimensional mapping of prion protein isoforms in human cerebrospinal fluid and central nervous system 192
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 192
Apolipoprotein C-III glycoforms correlate heterogeneously with plasma lipid profile in subjects with coronary artery disease 192
Altered paraoxonase expression in patients with genetic haemochromatosis. 191
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 190
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 190
"Exploring the hidden human urinary proteome via ligand library beads" 187
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 187
Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII 185
“Proteome analysis in the clinical chemistry laboratory: myth or reality?” 178
NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism. 176
Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis 176
A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431. 175
Epigenetics regulation of HSD11B2 gene by promoter methylation in glucocorticoid-treated patients 175
Plasma proteomic analysis of patients with Coronary Artery Disease with different levels of apolipoprotein CIII 175
Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up 174
“Proteomics approaches for studying chemoresistance in cancer” 173
Female urinary proteomics: New insight into exogenous and physiological hormone-dependent changes. 172
pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease 172
Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease 172
High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis 171
Monocyte/macrophage proteomics: recent findings and biomedical applications. 170
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS 169
Detection of urinary exosomal HSD11B2 mRNA expression: a useful novel tool for the diagnostic approach of dysfunctional 11β-HSD2-related hypertension 169
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 168
Surface plasmon resonance based on molecularly imprinted nanoparticles for the picomolar detection of the iron regulating hormone Hepcidin-25 168
Proteomic analysis of urinary extracellular vesicles highlights specific signatures for patients with primary aldosteronism 167
Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents 167
How to bring the "unseen" proteome to the limelight via electrophoretic pre-fractionation techniques 167
"Prefractionation of urinary proteins" 166
Increased plasma thrombin potential is associated with stable coronary artery disease: An angiographically-controlled study 166
Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII 166
Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome 166
Epigenetic control of 11-beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension 165
Prefractionation techniques in proteome analysis: the mining tools of the third millennium. 164
Amphoteric,buffering chromatographic beads for proteome prefractionation.I :theoretical model 163
High resolution preparation of monocyte-derived macrophages (MDM) protein fractions for clinical proteomics 161
Murine macrophages response to iron 161
Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy 161
Trace Elements Status and Metallothioneins DNA Methylation Influence Human Hepatocellular Carcinoma Survival Rate 160
Iron metabolism in Murine Macrophages: a proteomic insight. 158
Modern iron replacement therapy: clinical and pathophysiological insights 158
Serum Uric Acid Levels, but Not rs7442295 Polymorphism of SCL2A9 Gene, Predict Mortality in Clinically Stable Coronary Artery Disease 157
Epigenetic control of hydroxysteroid (11-beta) dehydrogenase 2 gene is related to human hypertension 152
The role of TMPRSS6 and HFE variants in iron deficiency anemia in celiac disease 151
A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels 151
Urinary prostasin: a candidate marker of ENaC activation in humans:study of preliminary feasibility 149
Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease 149
Optimizing the purification and analysis of miRNAs from urinary exosomes. 145
Hepcidin Inhibition by Modified Heparins without Anticoagulant Activity 144
Urinary Metabolic Signature of Primary Aldosteronism: Gender and Subtype-Specific Alterations 143
Sucrosomial® Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation 143
Myristic acid induces proteomic and secretomic changes associated with steatosis, cytoskeleton remodeling, endoplasmic reticulum stress, protein turnover and exosome release in HepG2 cells 143
“Critical survey of quantitative proteomics in two-dimensional electrophoretic approaches” 141
Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism 140
Imprinted polymers for the recognition/quantitation of the peptide hormone hepcidin 138
Plasma Proteome Profiles of Stable CAD Patients Stratified According to Total Apo C-III Levels 138
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. 137
Reduced serum hepcidin levels in patients with chronic hepatitis C 137
High Plasma Concentration of Apolipoprotein C-III Confers an Increased Risk of Cerebral Ischemic Events on Cardiovascular Patients Anticoagulated With Warfarin 137
Hepcidin assay in serum by SELDI-TOF-MS and other approaches 135
Associations between higher plasma ferritin and hepcidin levels with liver stiffness in patients with type 2 diabetes: An exploratory study 134
Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart disease 134
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 132
Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19 132
Carbamylation of proteins in 2-D electrophoresis--myth or reality? 131
Identification of Early Biomarkers of Mortality in COVID-19 Hospitalized Patients: A LASSO-Based Cox and Logistic Approach 129
null 129
“Conventional isoelectric focusing in gel slabs and capillaries and immobilized pH gradients” 128
Myristic acid plasma levels are strongly correlated with triglyceride and Apolipoprotein C-III plasma concentration in a cohort of subjects with or without coronary artery disease 128
Provisional standardization of hepcidin assays: creating a traceability chain with a primary reference material, candidate reference method and a commutable secondary reference material 127
Hormone-Dependent Changes in Female Urinary Proteome 124
Beta-elimination: an unexpected artefact in proteome analysis. 123
Circadian exosomal expression of renal thiazide-sensitive NaCl cotransporter (NCC) and prostasin in healthy individuals 121
Treatment options for anemia in the elderly 118
Hepcidin resistance in dysmetabolic iron overload 117
Urinary extracellular vesicle mRNA analysis of sodium chloride cotransporter in hypertensive patients under different conditions 117
Reducing protein concentration range of biological samples using solid-phase ligand libraries 115
Serum Erythroferrone in a Large General Population: Towards a Better Understanding of Connections Between Erythropoiesis and Iron Homeostasis 114
Totale 16.879
Categoria #
all - tutte 65.352
article - articoli 51.166
book - libri 0
conference - conferenze 12.618
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.568
Totale 130.704


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022750 0 256 8 63 25 25 7 37 43 18 75 193
2022/20232.027 120 231 167 335 199 474 31 127 261 12 36 34
2023/20241.075 43 88 72 106 117 209 21 69 12 29 189 120
2024/20252.503 125 183 123 427 97 94 128 86 344 160 209 527
2025/20269.103 562 407 887 1.525 2.285 574 854 445 631 527 143 263
2026/2027165 125 40 0 0 0 0 0 0 0 0 0 0
Totale 19.446